Her blir opprinnelig varestrøm mellom sone 417 og sone 217 splittet opp på fire strømmer mellom ulike bedrifter i disse to sonene. Jernbanedirektoratet

— End —

The world of sound technology is constantly evolving, with new innovations and advancements being made every day. One of the most exciting developments in recent years is SONE-217, a cutting-edge technology that is set to revolutionize the way we experience sound.

Tease/CTA: Stay tuned — SONE-217 is just beginning. What would you build, discover, or write if you held that label in your hands?

The future of SONE-217 looks bright, with several key milestones expected in the coming years. These include:

SONE‑217 (chemical name: ) is an orally bioavailable, highly selective small‑molecule modulator currently being developed by Sone Therapeutics Ltd. (formerly a spin‑out of the University of Cambridge’s Department of Chemical Biology).